Share Search
Visit the Share Search
Destiny Pharma. Accounts Summary
| Date of Accounts | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
| Revenue | n/a | n/a | n/a | n/a | n/a |
| Operating Profit / Loss | -6.74 | -7.78 | -6.02 | -6.55 | -5.58 |
| Net Interest | 0.29 | 0.07 | 0.02 | 0.07 | 0.06 |
| Pre Tax Profit | -6.45 | -7.71 | -6.27 | -6.48 | -5.52 |
| Post Tax Profit | -5.66 | -6.50 | -5.34 | -5.41 | -4.71 |
| Profit for the Period | -5.66 | -6.50 | -5.34 | -5.41 | -4.71 |
| Equity Holders of Parent Company | -5.66 | -6.50 | -5.34 | -5.41 | -4.71 |
| Minority Interests | n/a | n/a | n/a | n/a | n/a |
| Continuing EPS | |||||
| Earnings per Share (Basic) | -6.20p | -9.30p | -8.90p | -12.00p | -10.66p |
| Earnings per Share (Diluted) | -6.20p | -9.30p | -8.90p | -12.00p | -10.66p |
| Earnings per Share (Adjusted) | -6.20p | -9.30p | -8.90p | -12.00p | -10.66p |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | -6.20p | -9.30p | -8.90p | -12.00p | -10.66p |
| Earnings per Share (Diluted) | -6.20p | -9.30p | -8.90p | -12.00p | -10.66p |
| Earnings per Share (Adjusted) | -6.20p | -9.30p | -8.90p | -12.00p | -10.66p |
| Dividend per Share | n/ap | n/ap | n/ap | n/ap | n/ap |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
| Non-Current Assets | |||||
| Intangible Assets | 2.34 | 2.26 | 2.26 | 2.26 | n/a |
| Property, Plant and Equipment | 0.02 | 0.03 | 0.04 | 0.02 | 0.03 |
| Investments | n/a | n/a | n/a | n/a | n/a |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Other Financial Assets | 0.00 | n/a | n/a | n/a | n/a |
| Other Non-Current Assets | n/a | n/a | n/a | n/a | n/a |
| Total Non-Current Assets | 2.36 | 2.29 | 2.30 | 2.28 | 0.03 |
| Current Assets | |||||
| Inventories | n/a | n/a | n/a | n/a | n/a |
| Trade and Other Receivables | 1.21 | 1.61 | 1.34 | 1.68 | 1.04 |
| Cash at Bank and in Hand | 6.38 | 4.90 | 4.65 | 9.74 | 7.48 |
| Current Asset Investments | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | n/a | n/a | n/a | n/a | n/a |
| Total Current Assets | 7.60 | 6.51 | 5.99 | 11.42 | 8.52 |
| Other Assets | n/a | n/a | n/a | n/a | n/a |
| Total Assets | 9.96 | 8.80 | 8.28 | 13.70 | 8.56 |
| Current Liabilities | |||||
| Borrowings | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 0.77 | 1.17 | 0.77 | 1.27 | 0.80 |
| Total Current Liabilities | 0.77 | 1.17 | 0.77 | 1.27 | 0.80 |
| Net Current Assets | n/a | n/a | n/a | n/a | n/a |
| Non-Current Liabilities | |||||
| Borrowings | n/a | n/a | n/a | n/a | n/a |
| Provisions | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Liabilities | n/a | n/a | n/a | n/a | n/a |
| Total Non-Current Liabilities | n/a | n/a | n/a | n/a | n/a |
| Net Assets | 9.19 | 7.63 | 7.51 | 12.44 | 7.76 |
| Capital and Reserves | |||||
| Share Capital | 0.95 | 0.73 | 0.60 | 0.60 | 0.44 |
| Share Premium Account | 39.57 | 33.04 | 27.09 | 27.09 | 17.30 |
| Other Reserves | n/a | n/a | n/a | n/a | n/a |
| Retained Earnings | -31.33 | -26.15 | -20.18 | -15.25 | -9.98 |
| Shareholders Funds | 9.19 | 7.63 | 7.51 | 12.44 | 7.76 |
| Minority Interests / Other Equity | n/a | n/a | n/a | n/a | n/a |
| Total Equity | 9.19 | 7.63 | 7.51 | 12.44 | 7.76 |
| 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | |
| Operating Margin | n/a% | n/a% | n/a% | n/a% | n/a% |
| Return on Capital Employed | -98.36% | -144.96% | -119.80% | -64.35% | -71.91% |
| Dividend Cover | n/a | n/a | n/a | n/a | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | n/a | n/a | n/a | n/a | n/a |
| PEG | n/a | n/a | n/a | n/a | n/a |
| Dividend per Share Growth | n/a% | n/a% | n/a% | n/a% | n/a% |
| Net Asset Value per Share | 7.18p | 5.63p | 5.51p | 10.68p | 8.14p |